Net income
-71.9 million USD
2025-07-01 – 2026-06-30
Fundies. English
PepGen Inc.
EDGAR24 filing records in this dataset, filed from 2022-04-15 to 2026-08-06. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 22.8 million USD Source
Exact value
22764000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 68.9 million shares Source
Exact value
68874944 shares
Reported share-count change
111.15% · 36.3 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-69.3 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -65790000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -46531000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -81635000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -65790000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -18426000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -34232000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -18426000 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-06.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 5 of 11 periods available· newest 2025-12-31
- Net income: 5 of 11 periods available· newest 2025-12-31
- Operating cash flow: 5 of 11 periods available· newest 2025-12-31
- Capital expenditure: 5 of 11 periods available· newest 2025-12-31
- Total assets: 5 of 11 periods available· newest 2025-12-31
- Total liabilities: 5 of 11 periods available· newest 2025-12-31
- Current assets: 5 of 11 periods available· newest 2025-12-31
- Current liabilities: 5 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 5 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 5 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 326,000Prior period
−USD 89.98 million
–
Current period
−USD 89.66 million
–
Exact inputs and evidence
-89655000 − -89981000 = 326000 USD
-89981000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-89655000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 737,000Prior period
−USD 82.37 million
–
Current period
−USD 81.64 million
–
Exact inputs and evidence
-81635000 − -82372000 = 737000 USD
-82372000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-81635000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-46.9%Prior period
USD 497,000
–
Current period
USD 264,000
–
Exact inputs and evidence
264000 − 497000 = -233000 USD
497000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source264000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | −USD 27.28 million Exact valueExact value: -27281000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.6 million Exact valueExact value: -22599000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 500,000 Exact valueExact value: 500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 23.1 million Calculation and evidence-22599000 − 500000 USD Exact free cash flow: -23099000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 69.1 million Exact valueExact value: -69104000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.27 million Exact valueExact value: -59265000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.76 million Exact valueExact value: 3755000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63.02 million Calculation and evidence-59265000 − 3755000 USD Exact free cash flow: -63020000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 78.63 million Exact valueExact value: -78626000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 69 million Exact valueExact value: -68997000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.6 million Exact valueExact value: 2599000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 71.6 million Calculation and evidence-68997000 − 2599000 USD Exact free cash flow: -71596000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 89.98 million Exact valueExact value: -89981000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 82.37 million Exact valueExact value: -82372000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 497,000 Exact valueExact value: 497000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 82.87 million Calculation and evidence-82372000 − 497000 USD Exact free cash flow: -82869000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 89.66 million Exact valueExact value: -89655000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 81.64 million Exact valueExact value: -81635000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 264,000 Exact valueExact value: 264000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 81.9 million Calculation and evidence-81635000 − 264000 USD Exact free cash flow: -81899000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
24 filings · 1,152 latest values · 1,152 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001835597, 1835597, PEPG, edgar:1835597
Also known as PEPGEN INC., PepGen Inc.